Peter Scanlon

• Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age.

  Scanlon PH. et al, (2016), Diabet Med, 33, 1655 - 1658

• The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme.

  Oke JL. et al, (2016), Diabet Med, 33, 896 - 903

• Screening attendance, age group and diabetic retinopathy level at first screen.

  Scanlon PH. et al, (2016), Diabet Med, 33, 904 - 911

• Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening.

  Scanlon PH. et al, (2015), Health Technol Assess, 19, 1 - 116

• The use of weighted health-related Quality of Life scores in people with diabetic macular oedema at baseline in a randomized clinical trial.

  Scanlon PH. et al, (2015), Diabet Med, 32, 97 - 101

• Attitudes, access and anguish: a qualitative interview study of staff and patients' experiences of diabetic retinopathy screening.

  Hipwell AE. et al, (2014), BMJ Open, 4

• Influence of primary care practices on patients' uptake of diabetic retinopathy screening: a qualitative case study.

  Lindenmeyer A. et al, (2014), Br J Gen Pract, 64, e484 - e492

• Agreement between photographic screening and hospital biomicroscopy grading of diabetic retinopathy and maculopathy.

  Healy R. et al, (2014), Eur J Ophthalmol, 24, 550 - 558

• Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy.

  Scanlon PH. et al, (2014), Diabet Med, 31, 439 - 442

• Personalised risk estimation for progression to sight-threatening diabetic retinopathy: how much does clinical information add to screening data?

  Stratton IM. et al, (2014)

• Epidemiological issues in diabetic retinopathy.

  Scanlon PH. et al, (2013), Middle East Afr J Ophthalmol, 20, 293 - 300

• The influence of background diabetic retinopathy in the second eye on rates of progression of diabetic retinopathy between 2005 and 2010.

  Scanlon PH. et al, (2013), Acta Ophthalmol, 91, e335 - e339

• A simple risk stratification for time to development of sight-threatening diabetic retinopathy.

  Stratton IM. et al, (2013), Diabetes Care, 36, 580 - 585

• A grounded theory exploration of young adults' non-attendance at diabetic retinopathy screening appointments

  Laver FJ. et al, (2013)

• Which visual acuity measurements define high-quality care for patients with neovascular age-related macular degeneration treated with ranibizumab?

  Ross AH. et al, (2013), Eye (Lond), 27, 56 - 64

• Updating diabetic retinopathy screening lists using automatic extraction from GP patient records.

  Scanlon PH. et al, (2013), J Med Screen, 20, 111 - 117

• The preferences of people with diabetes for diabetic retinopathy screening.

  Scanlon PH., (2012), Diabet Med, 29, 836 - 837

• The systematic DR screening in england for two million people with diabetes

  Scanlon PH., (2012), Digital Teleretinal Screening: Teleophthalmology in Practice, 127 - 136

• A potential pathway for managing diabetic patients with arterial emboli detected by retinal screening.

  Hadley G. et al, (2011), Eur J Vasc Endovasc Surg, 42, 153 - 157

• Agreement and reasons for disagreement between photographic and hospital biomicroscopy grading of diabetic retinopathy.

  Sallam A. et al, (2011), Diabet Med, 28, 741 - 746

• Diabetic retinopathy

  Scanlon PH., (2010), Medicine, 38, 656 - 660

• Diabetic Retinopathy

  Scanlon PH., (2010), Textbook of Diabetes: Fourth Edition, 575 - 598

• The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea.

  West SD. et al, (2010), Diabet Med, 27, 423 - 430

• Why do patients still require surgery for the late complications of Proliferative Diabetic Retinopathy?

  Scanlon PH., (2010), Eye (Lond), 24, 435 - 440

• Image-quality standardization for diabetic retinopathy screening

  Taylor DJ. et al, (2009), Expert Review of Ophthalmology, 4, 469 - 476

• The Stable Treated Eye

  Scanlon PH., (2009), A Practical Manual of Diabetic Retinopathy Management, 137 - 143

• Stage R3: Proliferative Diabetic Retinopathy and Advanced Diabetic Retinopathy

  Scanlon PH., (2009), 109 - 132

• Stage R3 with M1: Proliferative Diabetic Retinopathy with Maculopathy

  Scanlon PH., (2009), A Practical Manual of Diabetic Retinopathy Management, 133 - 136

• Stage R2: Moderate and Severe Non-Proliferative Diabetic Retinopathy (Preproliferative Diabetic Retinopathy)

  Scanlon PH., (2009), A Practical Manual of Diabetic Retinopathy Management, 104 - 108

• Stage R1: Mild Non-Proliferative Diabetic Retinopathy (Background Diabetic Retinopathy)

  Scanlon PH., (2009), 99 - 103

• Stage M1: Maculopathy

  Scanlon PH., (2009), 70 - 98

• Screening for Diabetic Retinopathy

  Scanlon PH., (2009), 46 - 57

• Prologue

  Scanlon PH., (2009), A Practical Manual of Diabetic Retinopathy Management

• Pregnancy and the Diabetic Eye

  Scanlon PH., (2009), 151 - 159

• Other Retinal Conditions that are More Frequent in Diabetes

  Aldington SJ. and Scanlon PH., (2009), A Practical Manual of Diabetic Retinopathy Management, 178 - 193

• Low Vision and Blindness from Diabetic Retinopathy

  Scanlon PH., (2009), A Practical Manual of Diabetic Retinopathy Management, 160 - 170

• Lesions and Classifications of Diabetic Retinopathy

  Scanlon PH., (2009), 30 - 45

• Introduction

  Scanlon PH., (2009), 1 - 16

• Future Advances in the Management of Diabetic Retinopathy

  Scanlon PH., (2009), A Practical Manual of Diabetic Retinopathy Management, 171 - 177

• Diabetes

  Matthews DR. and Scanlon PH., (2009), A Practical Manual of Diabetic Retinopathy Management, 17 - 29

• Conditions with Appearances Similar to Diabetic Retinopathy

  Aldington SJ. and Scanlon PH., (2009), A Practical Manual of Diabetic Retinopathy Management, 194 - 202

• A Practical Manual of Diabetic Retinopathy Management

  Scanlon PH. et al, (2009), 1 - 214

• Prevalence of Retinopathy in Men with Type 2 Diabetes and Obstructive Sleep Apnoea.

  West SD. et al, (2009)

• NON-UNIFORM SPATIAL DISTRIBUTION OF MACULAR LESIONS IN TYPE 2 DIABETES

  Aldington SJ. et al, (2009)

• Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening.

  Scanlon PH. et al, (2008), Br J Ophthalmol, 92, 775 - 778

• Reply to 'Evaluation of the effect of JPEG and JPEG2000 image compression on the detection of diabetic retinopathy'.

  Atan D. et al, (2008), Eye (Lond), 22

• The English national screening programme for sight-threatening diabetic retinopathy.

  Scanlon PH., (2008), J Med Screen, 15, 1 - 4

• Diabetic retinopathy and socioeconomic deprivation in Gloucestershire.

  Scanlon PH. et al, (2008), J Med Screen, 15, 118 - 121

• The distribution of macular hard exudates is related to future visual acuity in subjects with type 2 diabetes

  Stratton IM. et al, (2007), DIABETOLOGIA, 50, S99 - S99

• Spatial distribution of newly-emergent macular hard exudates in patients with Type 2 diabetes

  Aldington SJ. et al, (2007)

• Reported symptoms and quality-of-life impacts in patients having laser treatment for sight-threatening diabetic retinopathy.

  Scanlon PH. et al, (2006), Diabet Med, 23, 60 - 66

• The influence of age, duration of diabetes, cataract, and pupil size on image quality in digital photographic retinal screening.

  Scanlon PH. et al, (2005), Diabetes Care, 28, 2448 - 2453

• An evaluation of the change in activity and workload arising from diabetic ophthalmology referrals following the introduction of a community based digital retinal photographic screening programme.

  Scanlon PH. et al, (2005), Br J Ophthalmol, 89, 971 - 975

• A pilot quality assurance scheme for diabetic retinopathy risk reduction programmes.

  Garvican L. and Scanlon PH., (2004), Diabet Med, 21, 1066 - 1074

• Comparison of two reference standards in validating two field mydriatic digital photography as a method of screening for diabetic retinopathy.

  Scanlon PH. et al, (2003), Br J Ophthalmol, 87, 1258 - 1263

• The effectiveness of screening for diabetic retinopathy by digital imaging photography and technician ophthalmoscopy.

  Scanlon PH. et al, (2003), Diabet Med, 20, 467 - 474

Recent Publications

• Risk of diabetic retinopathy at first screen in children at 12 and 13 years of age.

  Scanlon PH. et al, (2016), Diabet Med, 33, 1655 - 1658

• The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme.

  Oke JL. et al, (2016), Diabet Med, 33, 896 - 903

• Screening attendance, age group and diabetic retinopathy level at first screen.

  Scanlon PH. et al, (2016), Diabet Med, 33, 904 - 911

• Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening.

  Scanlon PH. et al, (2015), Health Technol Assess, 19, 1 - 116

• The use of weighted health-related Quality of Life scores in people with diabetic macular oedema at baseline in a randomized clinical trial.

  Scanlon PH. et al, (2015), Diabet Med, 32, 97 - 101